News|Articles|May 13, 2024
Pfizer CentreOne Perspectives: Sterile Injectable Capabilities and Responding to Emerging Trends
Author(s)Pfizer CentreOne
Sterile injectables (SI) and complex biologics can be leveraged from both a technical and business development standpoint. Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How the Wegovy Pill Approval Reshapes Solid Dosage Manufacturing Strategy
2
Innovation and Market Exclusivity in the EU
3
Harnessing Data and Secure Cloud Environments for Global Pharma Solutions
4
Orchestrating the Pharmaceutical Future: Living Decision Engines and AI Integration
5